| Identification | More | [Name]
1-(2-HYDROXYPHENYL)PIPERAZINE | [CAS]
1011-17-2 | [Synonyms]
1-(2-HYDROXYPHENYL)PIPERAZINE
2-(1-PIPERAZINO)PHENOL
LABOTEST-BB LT01596124
N-(2-HYDROXYPHENYL)PIPERAZINE
RARECHEM AH CK 0117
o-(1-piperazinyl)phenol
2-piperazin-1-ylphenol
2-(1-Piperazinyl) phenol
1-(2-Hydroxyphenyl)piperazine 98%
2-(1-PIPERAZINO)PHENOL 98%
2-Piperazinophenol | [EINECS(EC#)]
213-782-5 | [Molecular Formula]
C10H14N2O | [MDL Number]
MFCD00190246 | [Molecular Weight]
178.23 | [MOL File]
1011-17-2.mol |
| Chemical Properties | Back Directory | [Appearance]
brown-pink to brown powder and chunks | [Melting point ]
125-129 °C | [Boiling point ]
328.2±27.0 °C(Predicted) | [density ]
1.141 | [form ]
powder | [pka]
11.25±0.35(Predicted) | [color ]
pale brown | [BRN ]
10646 | [InChI]
1S/C10H14N2O/c13-10-4-2-1-3-9(10)12-7-5-11-6-8-12/h1-4,11,13H,5-8H2 | [InChIKey]
UORNTHBBLYBAJJ-UHFFFAOYSA-N | [SMILES]
Oc1ccccc1N2CCNCC2 | [CAS DataBase Reference]
1011-17-2(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
T,Xi | [Risk Statements ]
R25:Toxic if swallowed.
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S37/39:Wear suitable gloves and eye/face protection .
S45:In case of accident or if you feel unwell, seek medical advice immediately (show label where possible) . | [RIDADR ]
UN 2811 6.1/PG 3
| [WGK Germany ]
WGK 3 | [Hazard Note ]
Irritant | [HazardClass ]
8 | [PackingGroup ]
III | [HS Code ]
29339900 | [Storage Class]
6.1D - Non-combustible acute toxic Cat.3
toxic hazardous materials or hazardous materials causing chronic effects | [Hazard Classifications]
Acute Tox. 3 Oral
Eye Irrit. 2
Skin Irrit. 2
STOT SE 3 |
| Hazard Information | Back Directory | [Chemical Properties]
brown-pink to brown powder and chunks | [Uses]
2-(Piperazin-1-yl)phenol is used in preparation of substituted imidazoles and oxazoles in the treatment of cancers and other medical conditions. |
|
|